Process and intermediates for preparing integrase inhibitors

Details for Australian Patent Application No. 2007296555 (hide)

Owner Gilead Sciences, Inc.

Inventors Chen, Xi; Dowdy, Eric; Pfeiffer, Steven

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007296555

PCT Pub. Number WO2008/033836

Priority 60/905,365 07.03.07 US; 60/844,020 12.09.06 US

Filing date 11 September 2007

Wipo publication date 20 March 2008

Acceptance publication date 12 July 2012

International Classifications

C07B 49/00 Grignard reactions

C07C 43/205 Ethers

C07C 51/367 Preparation of carboxylic acids or their salts, halides, or anhydrides

C07C 63/68 Compounds having carboxyl groups bound to carbon atoms of six-membered aromatic rings

C07D 215/56 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 233/54 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/033836 Priority application(s): WO2008/033836

12 July 2012 Application Accepted

  Published as AU-B-2007296555

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007296556-Use of 2-6- (3-Amino-piperidin-l-yl) - 3-methyl-2, 4-dioxo-3, 4-dihydr0-2H-pyrimidin-1-ylmet hyl4-fluoro-benzonitrile

2007296550-Pyrimidines derivatives and their use as kinase inhibitors